Tasly Academy

Tasly Academy is the dedicated research and development division of Tasly Holding Group, a prominent global healthcare enterprise headquartered in Tianjin, China. The Academy is renowned for its pioneering work in the modernization of Traditional Chinese Medicine (TCM), applying rigorous scientific standards and advanced biotechnology to herbal pharmacology. Its core focus areas include cardiovascular diseases, metabolic disorders, and oncology, with a significant emphasis on its proprietary dropping pill formulation technology. Tasly Academy manages an extensive pipeline, most notably the T89 (Dantonic) herbal compound, which has undergone advanced clinical trials under US FDA supervision. Through international collaborations and a commitment to evidence-based medicine, the Academy seeks to integrate traditional therapeutic wisdom into the global mainstream pharmaceutical market.